Cooperative Agreement U01NS042940

Summary of Federal Cooperative Agreement Award The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $17.2 million Cooperative Agreement to The Leland Stanford Junior University on August 13, 2025, for the Cilostazol for Prevention of Recurrent Stroke (CLARITY) study, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). This clinical research initiative investigates the long-term efficacy of cilostazol—a...

Federal Cooperative Agreement Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Trustees of Columbia University in the City of New York a Cooperative Agreement totaling $1,225,804 (Award Date: September 9, 2025; Completion Date: August 31, 2026) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). This Phase 1 clinical trial will conduct a rigorous investigation of bilateral cerebellar deep brain...

Federal Cooperative Agreement Summary The National Institute on Deafness and Other Communication Disorders (NIDCD) awarded the University of South Carolina a $3.6 million Cooperative Agreement under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) on September 1, 2025, with a completion date of August 31, 2030. This award funds a prospective randomized controlled clinical trial investigating the superiority of transcranial direct current stimulation (tDCS)...

Federal Cooperative Agreement Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Ohio State University a Cooperative Agreement valued at $1,535,439 on September 15, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct the WINDSURFER trial (Win Ratio Analysis to Determine a Strategy of Non-Invasive Support for Respiratory Failure in the Emergency Department). This multi-site clinical trial is designed to determine the optimal non-invasive...

Federal Cooperative Agreement Summary The Medical University of South Carolina received a $688,047 Cooperative Agreement from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 1, 2025, with a completion date of August 31, 2031. The award funds the WINDSURFER trial (WIN Ratio Analysis to Determine a Strategy of Non-Invasive Support for Respiratory Failure in the Emergency Department), a clinical research...

The National Institute on Deafness and Other Communication Disorders (NIDCD) awarded a $429,000 Project Grant under the "Research Related to Deafness and Communication Disorders" (CFDA 93.173) federal grant program to The Medical College of Wisconsin, Inc. The grant aims to enhance language recovery and quality of life for stroke survivors with aphasia by combining a linguistically-motivated therapy called Semantic Feature Analysis (SFA) with excitatory theta burst stimulation (TBS), a...

This Project Grant award of $5,949,022, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will fund research to identify novel therapeutic targets for treating cerebral amyloid angiopathy (CAA) and vascular contributions to cognitive impairment and dementia (VCID). The research, led by the Jackson Laboratory with sub-awards to Emory University, Rush...

Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Cincinnati a Project Grant totaling $186,613 (obligated April 10, 2026) under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct a five-year neuroimaging research study extending through March 31, 2031. The research deliverables include the measurement and mapping of activated microglia density and distribution in the brains of 45 individuals with sickle cell disease...

Federal Grant Award Summary Yale University received a $1.26M Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) on May 9, 2025, with completion targeted for April 30, 2030. This research initiative examines anticoagulation therapy outcomes in intracerebral hemorrhage (ICH) survivors with atrial fibrillation (AF), with particular focus on how cerebral...

This $428,883 Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) aims to examine the effects of individualized transcranial alternating current stimulation (tACS) on phonological short-term memory performance in chronic stroke survivors with aphasia. The key objectives are to identify optimal tACS targets, frequency, and electric field coverage based on...